In Vitro Selective Inhibition of Human UDP-Glucuronosyltransferase (UGT) 1A4 by Finasteride and Prediction of In Vivo Drug–Drug Interactions

    November 2014 in “ Toxicology Letters
    Seung Hwan Lee, Jung Tak Park, Do-Yun Kim, Soo Kyung Bae, Young-Won Chin, Euichaul Oh
    Image of study
    TLDR Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.
    The study found that finasteride selectively inhibits the UGT1A4 enzyme in vitro, which could potentially lead to drug-drug interactions in vivo. However, the in vivo concentration of finasteride is not high enough to cause significant inhibition of UGT1A4. The study suggests that caution should be taken when administering drugs that are metabolized by UGT1A4 in combination with finasteride.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 1000+ results

      community (32M) Short-Term Progress Only with Min/Fin

      in Finasteride  117 upvotes 1 week ago
      A 32-year-old male experienced short-term hair regrowth with topical minoxidil, but thinning resumed. He switched to oral finasteride and minoxidil, saw initial improvement, but now faces aggressive thinning again and is considering other treatments like dutasteride, derma rollers, or red light caps.

      community Should I continue finasteride or quit?

      in Finasteride  99 upvotes 1 week ago
      A 19-year-old is considering whether to continue finasteride at 0.5mg every other day due to concerns about side effects. They are seeking advice on dosage frequency and potential side effects, noting no issues so far.

    Related Research

    1 / 1 results